F5 Provides Cost and Performance Enhancing Technology in Support of Open Source Telemetry Project

F5 Provides Cost and Performance Enhancing Technology in Support of Open Source Telemetry Project

Code contribution improves protocol compression ratio by 2x and reduces bandwidth costs for high-volume telemetry initiatives and AI-driven projects

F5 (NASDAQ: FFIV) today announced its continued support for Cloud Native Computing Foundation's OpenTelemetry , an open source framework providing a standardized collection of tools to instrument, generate, capture, and export telemetry data (metrics, logs, and traces) to help IT teams better analyze their solutions' performance and behavior. In a development partnership with ServiceNow, F5 has contributed approximately 40,000 lines of code to double the compressibility of the OpenTelemetry Protocol . This innovation reduces the costs of exporting data from data centers, clouds, and edge locations to a telemetry platform by half, depending on the specific data workload. To put the size of this contribution in perspective, the typical software developer produces between 10,000 and 25,000 lines of code each year and the average open source project comprises around 35,000 lines of code.

Optimizing the collection, ingestion, and analysis of telemetry data such as metrics, logs, and traces enables organizations to more efficiently and performantly deliver intelligent, automated responses amidst variable IT conditions. As an example, telemetry can help security teams detect and prevent fraudulent and nefarious activities by comparing login and behavioral characteristics of users and applications against typical usage patterns. Customers who export such telemetry data from public clouds to a telemetry aggregation system using this new refinement to the OpenTelemetry Protocol can expect their egress costs related to telemetry traffic to be reduced by 50%.

"Modern networking solutions, applications, and users generate unfathomably large volumes of data in the course of everyday operations, making compression rates essential to bringing the benefits of comprehensive telemetry to more organizations in a cost-effective manner," said Laurent Quérel, project lead and distinguished engineer at F5. "While today's enterprises are much better suited to capture and analyze data versus their historical counterparts, challenges have persisted around effective transport, centralization, and standardization, which is why F5 has invested in the OpenTelemetry project. By adopting OpenTelemetry across the F5 portfolio—and continuing to participate in leading open source efforts with organizations like ServiceNow—we see limitless use cases to make applications more adaptive to changes in their runtime environment via performance assessment, added efficiencies, and enhanced forensics while keeping customer costs to a minimum."

Beginning with attempts to further optimize the OpenTelemetry Protocol in the context of Apache Arrow to significantly increase processing speed and reduce bandwidth costs, F5 partnered with ServiceNow Cloud Observability to introduce the OpenTelemetry Arrow Project and reference implementation guidance. Apache Arrow is an open source technology enhancing big data, analytics, and machine learning used to provide standardized representations of structured and semi-structured data in a more actionable, digestible format and promote advanced telemetry capabilities.

For many organizations, transporting and processing such data efficiently accounts for a significant portion of the cost associated with telemetry pipelines. Standardizing telemetry is especially critical because sufficient observability and AI-driven analysis require a uniform intake of data points from the entire IT stack. Protocol enhancements and standards developed and refined within an open source community provide surrounding industries with a powerful ecosystem of projects and solution infrastructure to build out tailored capabilities specific to their organizations and users. This approach also gives F5 customers heightened visibility into the immediate factors impacting their applications, better positioning IT teams to make strategic investments over time.

"When Lightstep co-founded the OpenTelemetry project, our goal was to work within the open source community to help enterprises maximize visibility without increasing spend," said Daniel "Spoons" Spoonhower, chief architect at ServiceNow Cloud Observability, formerly known as Lightstep. "Through this work with F5, we're continuing to execute on what enterprises need—the ability to ship more data at a lower cost."

Additional Resources

About F5

F5 is a multi-cloud application services and security company committed to bringing a better digital world to life.​​​​​​​ F5 partners with the world's largest, most advanced organizations to secure and optimize every app and API anywhere—on premises, in the cloud, or at the edge. F5 enables organizations to provide exceptional, secure digital experiences for their customers and continuously stay ahead of threats. For more information, go to f5.com . (NASDAQ: FFIV)

You can also follow @F5 on Twitter or visit us on LinkedIn and Facebook for more information about F5, its partners, and technologies.

F5 is a trademark, service mark, or tradename of F5, Inc., in the U.S. and other countries. All other product and company names herein may be trademarks of their respective owners.

Source: F5, Inc.

Rob Gruening
F5
(206) 272-6208
r.gruening@f5.com

Holly Lancaster
WE Communications
(415) 547-7054
hluka@we-worldwide.com

News Provided by Business Wire via QuoteMedia

FFIV
The Conversation (0)
Sirona Biochem Announces Loan

Sirona Biochem Announces Loan

Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (" Sirona " or the " Company ") announced that it has entered into a demand grid promissory note (the " Note ") with 0906462 B.C. Ltd. (the " Lender ") for a loan in the aggregate principal amount of up to $1,000,000 (the " Loan "). Pursuant to the terms and conditions of the Note:

(a) the Loan is repayable on demand by the Lender;
(b) the Loan bears interest at a rate of 12% per annum, calculated yearly not in advance; and
(c) the Company has agreed to, subject to TSX Venture Exchange approval (" TSXV Approval "), issue the Lender 450,000 common shares in the capital of the Company (" Bonus Shares ") at a price of $0.12 per Bonus Share, as consideration for the risks taken by the Lender in providing the Company the Loan.

The Bonus Shares, if and when issued, will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Sirona Biochem Initiates Private Placement

Sirona Biochem Initiates Private Placement

Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the "Company") is pleased to announce a non-brokered private placement of up to 10,000,000 units of the Company at a price of $0.10 CAD per Unit (a "Unit") for gross proceeds of up to CAD$1,000,000 (the "Private Placement"). Each Unit consists of one common share and one transferable share purchase warrant, each whole warrant exercisable into one additional common share of the Company for a period of 2 years from the date of issue at a price of $0.15 per Share in year one and $0.25 per Share in year two.

In connection with the Private Placement, the Company may pay finders' fees of up to 10% in cash and 10% in Finder Warrants (the "Finder's Warrants"). Each Finder Warrant will entitle the holder to purchase one Share of the Company at any time for two years from the closing date of the Private Placement at a price of CAD$0.15 per Share in year one and CAD$0.25 per Share in year two.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories

Sirona Biochem Launches Cosmetics Subsidiary- Sirona Laboratories

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is proud to introduce Sirona Laboratories TM - a wholly-owned subsidiary dedicated to maximizing the commercial potential of its breakthrough anti-aging skincare ingredient, GlycoProteMim TM .

Dr. Howard Verrico, CEO and founder of Sirona Biochem, expressed his enthusiasm for the major milestone, stating that the establishment of Sirona Laboratories is meant to not just shape the future of the company, but to revolutionize the global anti-aging skincare market.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
The Stellantis Era Begins: Argentina Lithium  to drill up to 30 holes at Antofalla North Project

The Stellantis Era Begins: Argentina Lithium to drill up to 30 holes at Antofalla North Project

(TheNewswire)

Argentina Lithium & Energy Corp.

November 27, 2023 - TheNewswire - Global Stocks News - On November 20, 2023 Argentina Lithium (TSXV:LIT) (FSE:OAY3) (OTC:PNXLF) announced accelerated exploration plans for 2024 , following a $90 million (in ARS equivalent) financing agreement with Peugeot Citroen Argentina S.A., a subsidiary of Stellantis N.V.

LIT is exploring a number of highly prospective lithium projects in Argentina with a goal of advancing them toward production in order to meet the growing global demand from the battery sector.

"The revised program includes a plan to complete up to 30 drill holes at the Company's large and highly prospective Antofalla North project , with a goal of assessing its lithium resource potential shortly on the heels of the Company's flagship Rincon West project, where the 11th of 20 planned exploration drill holes is underway," stated LIT in the November 20, 2023 PR.


Click Image To View Full Size

The Stellantis deal gives Argentina Lithium the financial resources to accelerate the development of its lithium assets, while providing Stellantis with up to 15,000 tonnes of lithium per annum, for a 7-year period if LIT becomes a lithium producer.

Stellantis has a track record of making savvy upstream investments.

On August 17, 2023 Stellantis announced a $100 million investment in CTR to advance the development of a geothermal lithium project in California.


Click Image To View Full Size

Argentina Lithium's VP of Exploration, Miles Rideout , has lived in Mendoza, Argentina for more than 20 years. Fluent in English and Spanish, he has a track record in mine permitting, financing, construction, and operations, participating in the discovery of multiple world-class deposits.

" Our 2023 field work focused on drilling Rincon West and was extremely successful in identifying lithium-rich brines and advancing the project," stated Rideout. "At the same time, we assembled the large Antofalla North property package adjacent and to the north of Albemarle Corp's lithium project and now that we are funded [by the Stellantis deal] we will be as aggressive as possible to advance the project alongside Rincon West."

Antofalla North is undrilled, though it has been explored with geophysical techniques to 500 meters depth. LIT "hopes to delineate another major source of lithium in brines at Antofalla."


Click Image To View Full Size

Argentina Lithium plans to complete 110 line-km of TEM geophysics at the Antofalla North Project covering approximately 16,620 hectares . The objective is to identify targets for drilling of "an initial 6 broadly spaced reconnaissance holes" totaling approximately 2,400 metres to test for lithium brines.

With positive results, LIT plans to follow this work with as many as 24 infill holes or approximately 7,200 m of drilling to fully test the property holdings.

Miles Rideout recently spoke with Red Cloud TV's Mark Bunting about the Argentina program, including the Antofalla North project.

"Ricon West is the area we've been drilling for about 18 months," Rideout told Bunting. "Next year, we'll complete another 12 exploration holes, and likely between four and six pump tests as well assessing the quality of the aquifer. With that work done, we'll move forward with completing an initial mineral resource estimate."

"Our second lead project is Antofalla North," continued Rideout. "Our properties there are adjacent to Albemarle Corporation - the world's second largest lithium producer. We will be drilling beside the Albemarle properties, in the same basin. It's a large project."

On November 20, 2023, Argentina voted to elect a new President, Javier Milei.

"The wider energy complex appears to be turning in Milei's favor," reported Forbes . "Argentina has the world's second-largest lithium reserves estimated to be in the region of 20 million tons, according to the U.S. Geological Survey ."

"Domestic production of the metal that's desperately needed for the world's energy transition is ramping up, and might rise to as high as 120,000 t/year in 2024 (from a current level of around 60,000 t/year)".

LIT is part of the Grosso Group, which has a vast network of local and regional contacts in Argentina. The Grosso Group has formed strategic alliances and negotiated with mining majors such as Barrick, Teck, Newmont, Viceroy and Vale.

Argentina Lithium is currently awaiting the issuance of environmental permits at Antofalla which will allow work to begin.  LIT "does not foresee any issues with its applications."

"We have cleared the biggest hurdle for any junior today , which is having financing secured for all the planned exploration activity , to the tune of up to fifteen million dollars (US) next year alone if we complete all of our plans," stated Nikolaos Cacos, CEO of Argentina Lithium.

"In fact, the Stellantis funding is expected to carry us through exploration drilling to potential resource definition and initial engineering study stages at Rincon West and Antofalla North ," continued Cacos, "allowing us to build value with minimal dilution for our investors."

Contact: guy.bennett@globalstocksnews.com

Full Disclaimer

Copyright (c) 2023 TheNewswire - All rights reserved.

News Provided by TheNewsWire via QuoteMedia

Keep reading...Show less
Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy

Sirona Biochem: Investing News Network Interview with CSO, Dr. Geraldine Deliencourt-Godefroy

Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF) ("Sirona") is pleased to announce that the Investing News Network has published an exclusive video interview with Dr. Geraldine Deliencourt-Godefroy, the Chief Scientific Officer of Sirona.

In the interview, Dr. Deliencourt-Godefroy shares the remarkable story behind her groundbreaking discovery in anti-aging, TFC-1326, and discusses the recent clinical trial that showed exceptional results in aging skin without any adverse side effects.

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

Ă—